000 | 00914 a2200277 4500 | ||
---|---|---|---|
005 | 20250517202806.0 | ||
264 | 0 | _c20190222 | |
008 | 201902s 0 0 eng d | ||
022 | _a1474-5488 | ||
024 | 7 |
_a10.1016/S1470-2045(18)30150-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWarner, Allison Betof | |
245 | 0 | 0 |
_aThe brim of uncertainty in adjuvant treatment of melanoma. _h[electronic resource] |
260 |
_bThe Lancet. Oncology _c04 2018 |
||
300 |
_a436-437 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMelanoma |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aUncertainty |
650 | 0 | 4 | _aVemurafenib |
700 | 1 | _aPostow, Michael A | |
773 | 0 |
_tThe Lancet. Oncology _gvol. 19 _gno. 4 _gp. 436-437 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(18)30150-5 _zAvailable from publisher's website |
999 |
_c28119387 _d28119387 |